ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

P SaibabaSubscribe to P Saibaba

TRIPS and India's Pharmaceuticals Industry

Major changes can be expected in the Indian pharmaceuticals industry from 2005 due to the agreement on TRIPS, under which India will be required to introduce product patents for pharmaceutical products. This will likely lead to sharp increases in the prices of newly patented drugs. Although the TRIPS agreement may also lead to increased research on diseases common in developing countries, these benefits can be obtained in alternative ways, and without high costs. Thus, the TRIPS agreement is not in the national interest and should be renegotiated.

Indian Economy, 1995-96 to 1997-98-Alternative Scenarios

Indian Economy, 1995-96 to 1997-98 Alternative Scenarios K Krishnamurty V Pandit T Palanivel P Saibaba D Pratap At the macro level the Indian economy seems to have acquired strength and is likely to move forward with confidence in the foreseeable future. Revival of industry, strong export growth and gradually declining inflation are pointers that the fundamentals of the economy are right.
Back to Top